These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37015321)

  • 1. Conjunction of semi-mechanistic in vitro-in vivo modeling and population pharmacokinetics as a tool for virtual bioequivalence analysis - a case study for a BCS class II drug.
    Danielak D; Paszkowska J; Staniszewska M; Garbacz G; Terlecka A; Kubiak B; Romański M
    Eur J Pharm Biopharm; 2023 May; 186():132-143. PubMed ID: 37015321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing virtual bioequivalence and clinically relevant specifications using in vitro biorelevant dissolution testing and physiologically-based population pharmacokinetic modeling. case example: Naproxen.
    Loisios-Konstantinidis I; Cristofoletti R; Fotaki N; Turner DB; Dressman J
    Eur J Pharm Sci; 2020 Feb; 143():105170. PubMed ID: 31783158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing Virtual Bioequivalence and Clinically Relevant Specifications for Omeprazole Enteric-Coated Capsules by Incorporating Dissolution Data in PBPK Modeling.
    Yang R; Lin Y; Chen K; Huang J; Yang S; Yao A; Yang X; Lei D; Xiao J; Yang G; Pei Q
    AAPS J; 2024 Jul; 26(4):82. PubMed ID: 38997548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug dissolution and transit in a heterogenous gastric chyme after fed administration: Semi-mechanistic modeling and simulations for an immediate-release and orodispersible tablets containing a poorly soluble drug.
    Danielak D; Gajda M; Bołtromiuk T; Sulikowska K; Kubiak B; Romański M
    Eur J Pharm Biopharm; 2024 Jul; 200():114341. PubMed ID: 38795785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro In Vivo Extrapolation and Bioequivalence Prediction for Immediate-Release Capsules of Cefadroxil Based on a Physiologically-Based Pharmacokinetic ACAT Model.
    Rahim N; Naqvi SBS
    AAPS PharmSciTech; 2024 May; 25(5):100. PubMed ID: 38714602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model-Based Analysis of Biopharmaceutic Experiments To Improve Mechanistic Oral Absorption Modeling: An Integrated in Vitro in Vivo Extrapolation Perspective Using Ketoconazole as a Model Drug.
    Pathak SM; Ruff A; Kostewicz ES; Patel N; Turner DB; Jamei M
    Mol Pharm; 2017 Dec; 14(12):4305-4320. PubMed ID: 28771009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologically Based Pharmacokinetics Modeling in Biopharmaceutics: Case Studies for Establishing the Bioequivalence Safe Space for Innovator and Generic Drugs.
    Wu D; Sanghavi M; Kollipara S; Ahmed T; Saini AK; Heimbach T
    Pharm Res; 2023 Feb; 40(2):337-357. PubMed ID: 35840856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of fasted and fed bioequivalence for immediate release drug products using physiologically based biopharmaceutics modeling (PBBM).
    Jereb R; Kristl A; Mitra A
    Eur J Pharm Sci; 2020 Dec; 155():105554. PubMed ID: 32946959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient drug development of oseltamivir capsules based on process control, bioequivalence and PBPK modeling.
    Medeiros JJS; Costa TM; Carmo MP; Nascimento DD; Lauro ENC; Oliveira CA; Duque MD; Prado LD
    Drug Dev Ind Pharm; 2022 Apr; 48(4):146-157. PubMed ID: 35876070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of in vitro biorelevant dissolution and in silico PBPK model of carvedilol to predict bioequivalence of oral drug products.
    Ibarra M; Valiante C; Sopeña P; Schiavo A; Lorier M; Vázquez M; Fagiolino P
    Eur J Pharm Sci; 2018 Jun; 118():176-182. PubMed ID: 29605455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico prediction of bioequivalence of atorvastatin tablets based on GastroPlus™ software.
    Wang L; Chen J; Chen W; Ruan Z; Lou H; Yang D; Jiang B
    BMC Pharmacol Toxicol; 2023 Nov; 24(1):69. PubMed ID: 38017512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Untangling Absorption Mechanisms and Variability in Bioequivalence Studies Using Population Analysis.
    Ameijeiras Rodríguez C; Henriques SC; Sancho-Araiz A; Trocóniz IF; Almeida L; Silva NE
    Pharm Res; 2021 Dec; 38(12):2047-2063. PubMed ID: 34932170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PBPK Absorption Modeling of Food Effect and Bioequivalence in Fed State for Two Formulations with Crystalline and Amorphous Forms of BCS 2 Class Drug in Generic Drug Development.
    Rebeka J; Jerneja O; Igor L; Boštjan P; Aleksander B; Simon Ž; Albin K
    AAPS PharmSciTech; 2019 Jan; 20(2):59. PubMed ID: 30623248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen and ketoprofen.
    Tsume Y; Langguth P; Garcia-Arieta A; Amidon GL
    Biopharm Drug Dispos; 2012 Oct; 33(7):366-77. PubMed ID: 22815122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the Pharmacokinetics of Orally Administered Drugs across BCS Classes 1-4 by Virtual Bioequivalence Model.
    Zhang F; Wu X; Wu K; Yu M; Liu B; Wang H
    Mol Pharm; 2023 Jan; 20(1):395-408. PubMed ID: 36469444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards Virtual Bioequivalence Studies for Oral Dosage Forms Containing Poorly Water-Soluble Drugs: A Physiologically Based Biopharmaceutics Modeling (PBBM) Approach.
    Kambayashi A; Dressman JB
    J Pharm Sci; 2022 Jan; 111(1):135-145. PubMed ID: 34390740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologically Based Biopharmaceutics Modeling to Demonstrate Virtual Bioequivalence and Bioequivalence Safe-space for Ribociclib which has Permeation Rate-controlled Absorption.
    Laisney M; Heimbach T; Mueller-Zsigmondy M; Blumenstein L; Costa R; Ji Y
    J Pharm Sci; 2022 Jan; 111(1):274-284. PubMed ID: 34678270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Predictive Dissolution Test Should Be Developed and Recommended as a Bioequivalence Standard for the Immediate-Release Solid Oral Dosage Forms of the Highly Variable Mycophenolate Mofetil.
    Wang K; Li Y; Chen B; Chen H; Smith DE; Sun D; Feng MR; Amidon GL
    Mol Pharm; 2022 Jul; 19(7):2048-2060. PubMed ID: 35603895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro dissolution similarity factor (f2) and in vivo bioequivalence criteria, how and when do they match? Using a BCS class II drug as a simulation example.
    Xie F; Ji S; Cheng Z
    Eur J Pharm Sci; 2015 Jan; 66():163-72. PubMed ID: 25315411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.